NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE Drug Patent Profile
✉ Email this page to a colleague
When do Naphazoline Hydrochloride And Pheniramine Maleate patents expire, and what generic alternatives are available?
Naphazoline Hydrochloride And Pheniramine Maleate is a drug marketed by Altaire Pharms Inc and Rising and is included in two NDAs.
The generic ingredient in NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE is naphazoline hydrochloride; pheniramine maleate. There are eight drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the naphazoline hydrochloride; pheniramine maleate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Naphazoline Hydrochloride And Pheniramine Maleate
A generic version of NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE was approved as naphazoline hydrochloride; pheniramine maleate by ALTAIRE PHARMS INC on September 27th, 2010.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE?
- What are the global sales for NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE?
- What is Average Wholesale Price for NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE?
Summary for NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 2 |
| Clinical Trials: | 1 |
| Patent Applications: | 10 |
| DailyMed Link: | NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE at DailyMed |
Recent Clinical Trials for NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| EMS | Phase 3 |
See all NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE clinical trials
US Patents and Regulatory Information for NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Altaire Pharms Inc | NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE | naphazoline hydrochloride; pheniramine maleate | SOLUTION/DROPS;OPHTHALMIC | 078208-001 | Sep 27, 2010 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Rising | NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE | naphazoline hydrochloride; pheniramine maleate | SOLUTION/DROPS;OPHTHALMIC | 202795-001 | Jan 24, 2013 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
